These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 14836997)

  • 1. [The effect of serum from patients treated with conteben upon growth of the tubercle bacillus. III. The behavior of bacteria resistant to conteben; an indirect method of determining conteben blood levels].
    GEKS FJ
    Z Hyg Infektionskr; 1951; 132(2):162-72. PubMed ID: 14836997
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of the effect of conteben on the tubercle bacillus; the effect of conteben therapy upon the morphology and virulence of tubercle bacilli present in the sputum].
    BIENENGRABER A; URBACH H
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 105(1):68-82. PubMed ID: 14820743
    [No Abstract]   [Full Text] [Related]  

  • 3. [On method in the determination of the tubercle bacillus' resistance to conteben].
    WAGNER WH; SCHMIDT J
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1952; 107(6):453-9. PubMed ID: 13032011
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tubercle bacillus resistance and the drug blood level during conteben, PAS and streptomycin therapy of pulmonary tuberculosis].
    HOFMANN P; NICKEL L
    Tuberkulosearzt; 1950 Dec; 4(12):695-702. PubMed ID: 14809773
    [No Abstract]   [Full Text] [Related]  

  • 5. The sensitivity and resistance of tubercle bacilli to conteben (TB1/698).
    KANAI K; YANAGISAWA K
    Jpn J Med Sci Biol; 1953 Oct; 6(5):513-22. PubMed ID: 13142764
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combined therapy of urogenital tuberculosis with specific substances of tubercle bacillus (tebeprotin, phthioic acid phosphatide and conteben)].
    TOENNIESSEN E; KORNBECK E
    Med Klin; 1951 Jun; 46(24):687-8. PubMed ID: 14862813
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the metabolism of the tubercle bacillus following conteben administration with the aid of Warburg's method; contribution to the problem of virulence change following thiosemicarbazone administration].
    VELTMAN G; MIETHKE K
    Arztl Wochensch; 1953 Mar; 8(12):276-80. PubMed ID: 13057788
    [No Abstract]   [Full Text] [Related]  

  • 8. [Conteben resistant tuberculosis bacteria].
    POTHMANN FJ; REINECKE G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 105(5):487-97. PubMed ID: 14858262
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of serum from tuberculosis patients treated with Tb1/698 upon the growth of the tubercle bacillus].
    GEKS FJ
    Zentralbl Bakteriol Orig; 1950 Jul; 155(8):409-14. PubMed ID: 14782664
    [No Abstract]   [Full Text] [Related]  

  • 10. [Animal experiments on the physiology of tubercle bacilli in foci of skin tuberculosis treated with conteben and vitamin D2].
    VELTMAN G
    Arch Dermatol Syph; 1951 Nov; 193(4):305-24. PubMed ID: 14944185
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect in vitro of conteben, streptomycin, and PAS on TB-VI-resistant tubercle bacilli].
    von VIETINGHOFF-SCHEEL O
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 105(4):354-61. PubMed ID: 14847988
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of conteben and vitamin D2 therapy on Mycobacterium tuberculosis; comparative investigations on the conteben sensitivity in vitro and the course of skin tuberculosis under conteben therapy].
    VELTMAN G
    Zentralbl Bakteriol Orig; 1952 Aug; 158(6):417-25. PubMed ID: 13006962
    [No Abstract]   [Full Text] [Related]  

  • 13. [Resistance determination of tubercle bacteria against streptomycin, PAS, conteben, isoniazid and paratebin].
    VON VIETINGHOFF-SCHEEL O
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1953; 108(6):490-501. PubMed ID: 13081562
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on distribution, resorption and excretion of the labeled conteben].
    HINRICHS K; POPPE H; STEYER H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1953; 218(3):193-8. PubMed ID: 13087351
    [No Abstract]   [Full Text] [Related]  

  • 15. [Distribution, resorption and excretion following repeated oral administration of conteben. II].
    HINRICHS K; POPPE H; STEYER H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1954; 221(1):6-13. PubMed ID: 13154417
    [No Abstract]   [Full Text] [Related]  

  • 16. [The relation of in vitro conteben sensitivity to conteben therapy; a study on conteben resistant tuberculosis strains].
    VELTMAN G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1952; 106(5):413-20. PubMed ID: 14925075
    [No Abstract]   [Full Text] [Related]  

  • 17. [Resorption of conteben and p-aminosalicylic acid following intracavitary instillation].
    WILDE W; RUCK KH
    Med Monatsschr; 1950 Aug; 4(8):601-3. PubMed ID: 15438651
    [No Abstract]   [Full Text] [Related]  

  • 18. [Practical viewpoints of resistance against streptomycin, PAS, conteben].
    UNHOLTZ K
    Tuberkulosearzt; 1952 Aug; 6(8):451-9. PubMed ID: 13005732
    [No Abstract]   [Full Text] [Related]  

  • 19. [Resistance of tubercle bacteria toward streptomycin, PAS and conteben in vivo and in vitro].
    HOFMANN P; NICEL L
    Tuberkulosearzt; 1952 Jan; 6(1):7-15. PubMed ID: 14942904
    [No Abstract]   [Full Text] [Related]  

  • 20. [The sensitivity of INH-resistant tubercle bacteria to thiosemicarbazones (conteben)].
    BARTMANN K
    Tuberkulosearzt; 1960 Jul; 14():450-2. PubMed ID: 13687467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.